about o2h kickstarter
o2h Discovery is a fully integrated Anglo-Indian CRO with a global client base. The o2h kickstarter competition has been developed to provide a boost to small molecule focused biotechnology companies which have usually raised some initial funding and need to supercharge their chemistry efforts to meet their next funding milestone. We at o2h Discovery are driven by innovations in medicinal chemistry drug discovery research that develops new drugs and therapies for various diseases, satisfying the unmet needs for healthy human life and well-being.
winners feedback from the first competition
More than 30 companies applied from across the globe, and here are the six companies who made it to the winners list.
Dr Neil Benson
CEO
Winning the o2h Kickstarter competition will significantly increase our chemistry resource and in turn accelerate delivery of our goals.
Read more onLinkedIn
Jason Rutt
CEO
We are absolutely delighted to win an inaugural kickstarter award. It's fantastic that one of Britains top CROs is prepared to back companies like ours.
Read more onLinkedIn
Chris Moody
Co-founder
the o2h kickstarter competition promises to be an excellent scheme allowing early-stage companies like ours to get access to synthetic chemistry.
Read more onLinkedIn
Vid Stojevic
CEO & Co-founder
The kickstarter provides vital access to chemists with the skills and knowledge to deliver on the promise of our technology.
Read more onLinkedIn
Dr Janette A Thomas
CEO
I am thrilled that Five Alarm Bio has been awarded the Kickstarter program. We will benefit from the extensive knowledge and enthusiasm of the o2h leadership and laboratory scientists.
Read more onLinkedIn
Beth J Hoffman
President & CEO
The Kickstarter will enable us to thoroughly explore our nascent SAR and advance our lead program more rapidly.
Read more onLinkedInbenefits
team
Dedicated team of six FTE synthetic chemists of which two are fully trained and four are trainees.
cost
Six synthetic chemists at approximately the cost of one FTE.
inventory
Access to a large inventory of chemicals and reagents for synthesis.
duration
The programme would be offered up to six months.
eligibility
The competition is for pre-seed stage small molecule focused biotech companies which have secured initial funding from recognized grant bodies or venture/angel investors, has exciting drug targets and ability to scale.
Know moreevaluation
The applications will be evaluated by the o2h Kickstarter committee and 3 winners will be announced soon. This is a time limited competition. If supportive to the global biotech ecosystem we will run this again.
evaluation committee
Sunil Shah
Business Analysis
Business Analysis
Gayathri Sadasivam
Scientific Analysis, Biology
Scientific Analysis, Biology
Andy Morley
Scientific Analysis, Drug Discovery
Scientific Analysis, Drug Discovery
Hemal Soni
Scientific, Chemistry Synthesis
Scientific, Chemistry Synthesis
